Rheumatoid arthritis (RA) is a chronic autoimmune disease in which your immune system mistakenly attacks the lining of your joints, causing pain, swelling, and stiffness. About 18 million people worldwide live with RA, and roughly 70% of them are women. Unlike osteoarthritis, which results from wear and tear on cartilage, RA is driven by inflammation that can affect your entire body, not just your joints.
How RA Affects Your Joints
Every joint is surrounded by a thin membrane called the synovium, which normally produces a small amount of fluid to keep the joint lubricated. In RA, your immune system treats this membrane as a threat and sends inflammatory cells to attack it. The membrane thickens, swells, and produces excess fluid, which is what causes the warmth, puffiness, and tenderness you feel in an affected joint.
Over time, this chronic inflammation can erode the cartilage and bone within the joint itself. That erosion is what leads to the deformity and loss of function that people associate with advanced RA. The damage is irreversible once it occurs, which is why early treatment matters so much. Research consistently shows that starting treatment within the first three months of symptoms is associated with less joint damage and higher rates of remission compared to waiting longer.
Symptoms Beyond the Joints
RA typically starts in the small joints of the hands and feet, often symmetrically (both wrists at once, for example). Morning stiffness lasting longer than 30 minutes is a hallmark early sign, distinguishing it from osteoarthritis, where stiffness tends to ease within a few minutes. Fatigue is another common early symptom, sometimes appearing before joint problems become obvious.
Because RA is a systemic disease, it doesn’t stop at the joints. The same inflammatory process can affect your heart, lungs, eyes, and blood vessels. The cardiovascular risk is significant: people with RA have a roughly 48% higher risk of cardiovascular events like heart attacks and strokes, and a 50% higher rate of cardiovascular death compared to the general population. This elevated risk comes from chronic inflammation accelerating the buildup of plaque in arteries and affecting heart muscle tissue directly.
Who Gets RA
Women are two to three times more likely to develop RA than men, likely due to hormonal factors, though the exact reason isn’t fully understood. The disease most commonly appears between ages 30 and 60, but it can start at any age, including in childhood (called juvenile idiopathic arthritis). Smoking is the strongest known environmental risk factor, and having a family history of RA increases your likelihood as well. Certain genetic markers related to immune function play a role, but most people with those genes never develop the disease.
How RA Is Diagnosed
There is no single test that confirms RA. Doctors use a combination of physical examination, blood tests, and imaging to build a diagnosis. The standard classification system requires at least one visibly swollen joint that can’t be explained by another condition, then assigns points across four categories: how many and which joints are involved, blood test results, markers of inflammation, and how long symptoms have lasted. A score of 6 out of 10 or higher meets the threshold for an RA classification.
Two blood tests are particularly useful. Rheumatoid factor (RF) is the older, more familiar test, but it has a specificity of only about 85%, meaning 15% of people who test positive don’t actually have RA. Anti-CCP antibodies are more precise, with a specificity of 95 to 96%, making a positive result much more reliable. Both tests have similar sensitivity (catching 53 to 71% of true cases), so a negative result on either one doesn’t rule RA out. Doctors also check for elevated inflammation markers in the blood, which add supporting evidence.
X-rays and ultrasound can reveal early joint erosion or inflammation in the synovium, sometimes before you can feel it. These imaging tools help doctors gauge how aggressively the disease is progressing.
Treatment Options
The first-line treatment for RA is a class of medications called disease-modifying antirheumatic drugs (DMARDs), which work by suppressing the overactive immune response rather than just managing pain. Methotrexate, taken once a week as a pill, is the most widely used. It slows joint damage and is typically the starting point for most people newly diagnosed with RA.
If methotrexate alone isn’t enough, doctors often add biologic therapies. These are injectable or infused medications that target specific parts of the immune system driving the inflammation, such as proteins called TNF or IL-6 that amplify the inflammatory cascade in your joints. A meta-analysis of 21 studies found that about 53% of patients on biologics achieved remission overall, and when followed for 6 to 12 months, that number rose to 67%. These are meaningful odds, though results vary depending on how early treatment starts and how the disease responds.
A newer class of oral medications called JAK inhibitors offers another option for people who don’t respond well to methotrexate or biologics. Three are currently approved for RA in the United States: tofacitinib (approved in 2012), baricitinib (2018), and upadacitinib (2019). These drugs block signaling pathways inside immune cells, reducing inflammation through a different mechanism than biologics.
The overarching strategy in modern RA treatment is called “treat to target,” meaning your doctor will adjust medications with the goal of reaching remission or, at minimum, low disease activity. This approach requires regular follow-up visits and sometimes switching medications until the right combination is found.
Living With RA
Diet won’t replace medication, but it can complement it. A clinical trial found that RA patients who followed a Mediterranean diet (rich in fish, olive oil, vegetables, and whole grains) for several months experienced a measurable reduction in disease activity, improved physical function, and better energy levels compared to a control group that made no dietary changes. The anti-inflammatory properties of omega-3 fatty acids and polyphenols in these foods likely contribute to the benefit.
Regular physical activity is equally important. Low-impact exercise like swimming, cycling, and walking helps maintain joint mobility, strengthens the muscles supporting your joints, and reduces fatigue. Many people with RA avoid exercise out of fear of worsening pain, but consistent gentle movement generally improves symptoms rather than aggravating them. Physical and occupational therapy can also teach joint-protection techniques for everyday tasks like opening jars or typing.
RA is a lifelong condition, but outcomes have improved dramatically over the past two decades. With early diagnosis and modern treatment, many people maintain normal or near-normal function for years. The key variable is time: the sooner treatment begins after symptoms start, the better the long-term outlook for preserving your joints and overall health.